Precision BioSciences Earns FDA Orphan Drug Status for Duchenne Muscular Dystrophy
July 23, 2025
Precision BioSciences has been given Orphan Drug Designation by the U.S. Food and Drug Administration for its new treatment, PBGENE DMD, which is being developed
